Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7.

Significant Facility-Level Variation in Utilization of and Adherence with Secondary Prevention Therapies Among Patients with Premature Atherosclerotic Cardiovascular Disease: Insights from the VITAL (Veterans wIth premaTure AtheroscLerosis) Registry7. Cardiovasc Drugs Ther. 2022 02; 36(1):93-102.

View in: PubMed

subject areas

Adult
Aged
Atherosclerosis
Cardiovascular Diseases
Cohort Studies
Cross-Sectional Studies
Female
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Medication Adherence
Middle Aged
Platelet Aggregation Inhibitors
Registries
Secondary Prevention
Veterans

authors with profiles

CHRISTIE BALLANTYNE
LAURA PETERSEN
SALIM VIRANI
MAHBOOB ALAM